News | February 25, 2022
Risk appetite key to innovation in pharma and biopharma
Industry leaders discusses the need of innovation for the Indian drug industry at BioAsia 2022.
Industry leaders discusses the need of innovation for the Indian drug industry at BioAsia 2022.
The dedicated HPB and liver transplant centre will be headed by Dr. Vivek Vij, Chairman -Advanced Surgical GI, HPB & Liver Transplant and his team of experts
The Genome Valley region has played a pivotal role in fostering the life science industry and the state government has always supported its growth
He will continue to lead business in LATAM and Asia regions in this new role
US $ 555,000 invested by Wavemaker Partners in pre-seed round
The researchers are of the view that the new drug designing strategy demonstrated by them could also be adopted to treat retroviral infections.
According to Fortune Business Insights, the launch of new PCR-based detection techniques will lead to a surge in demand for PCR instruments in the coming years
Equity investment follows recent EUR 520 m licensing agreement providing Grand Pharma (GP) access to three of ITM’s targeted radionuclide therapeutic and diagnostic candidates for Greater China
The funds will be used to expand digital product offerings, grow their online customer base, and launch their flagship clinic in Bengaluru
Key takeaways of Q3FY22 quarter & conference call highlights
Subscribe To Our Newsletter & Stay Updated
